Clinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancer

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 493-499

  Tsuchiya, Norihiko ^a   Narita, Shintaro ^a   Kumazawa, Teruaki ^a   Inoue, Takamitsu ^a   Ma, Zhiyong ^a   Tsuruta, Hiroshi ^a   Saito, Mitsuru ^a   Horikawa, Yohei ^a   Yuasa, Takeshi ^a   Satoh, Shigeru ^a   Ogawa, Osamu ^b   Habuchi, Tomonori ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Allelic imbalance; Matrix metalloproteinase 1; Polymorphis; Prostate cancer

Indexed keywords

INTERSTITIAL COLLAGENASE;

AGED; ALLELIC IMBALANCE; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CHROMOSOME 11Q; CLINICAL EVALUATION; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; PROSTATE TUMOR;

AGED; ALLELIC IMBALANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS;

EID: 70349309842     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000462     Document Type: Article

References (37)

1. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
2. Pulukuri SM and Rao JS: Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol 32: 757-765, 2008.
3. Murray GI, Duncan ME, O'Neil P, Melvin WT and Fothergil JE: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2: 461-462, 1996.
4. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N and Nakamura Y: Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59: 4225-4227, 1999.
5. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT and Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 185: 256-261, 1998.
6. Ala-Aho R and Kahari VM: Collagenases in cancer. Biochimie 87: 273-286, 2005.
7. Murray GI, Duncan ME, Arbuckle E, Melvin WT and Fothergill JE: Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43: 791-797, 1998.
8. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM and Pyrhonen S: High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 97: 432-438, 2002.
9. Pardo A and Selman M: MMP-1: the elder of the family. Int J Biochem Cell Biol 37: 283-288, 2005.
10. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ and Brinckerhoff CE: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58: 5321-5325, 1998.
11. Tower GB, Coon CI and Brinckerhoff CE: The 2G single nucleotide polymorphism (SNP) in the MMP-1 promoter contributes to high levels of MMP-1 transcription in MCF-7/ADR breast cancer cells. Breast Cancer Res Treat 82: 75-82, 2003.
12. Nishioka Y, Kobayashi K, Sagae S, Ishioka S, Nishikawa A, Matsushima M, Kanamori Y, Minaguchi T, Nakamura Y, Tokino T and Kudo R: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91: 612-615, 2000.
13. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E and Scorza R: Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7: 2344-2346, 2001.
14. Zhu Y, Spitz MR, Lei L, Mills GB and Wu X: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61: 7825-7829, 2001.
15. Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G and Christiani DC: Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 14: 567-570, 2005.
16. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, Hazama S, Kitamura Y, Kamatani N and Oka M: Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer 102: 526-529, 2002.
17. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y and Hinoda Y: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 106: 372-374, 2003.
18. Elander N, Soderkvist P and Fransen K: Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26: 791-795, 2006.
19. Nishizawa R, Nagata M, Noman AA, Kitamura N, Fujita H, Hoshina H, Kubota T, Itagaki M, Shingaki S, Ohnishi M, Kurita H, Katsura K, Saito C, Yoshie H and Takagi R: The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma. BMC Cancer 7: 187, 2007.
20. Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A and Koksal V: A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. BJU Int 101: 503-507, 2008.
21. Nishioka Y, Sagae S, Nishikawa A, Ishioka S and Kudo R: A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. Cancer Lett 200: 49-55, 2003.
22. Matsumura S, Oue N, Kitadai Y, Chayama K, Yoshida K, Yamaguchi Y, Toge T, Imai K, Nakachi K and Yasui W: A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 130: 259-265, 2004.
23. Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger A, Blons H and Laurent-Puig P: Pro-gnostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res 11: 594-599, 2005.
24. Carneiro A, Isinger A, Karlsson A, Johansson J, Jonsson G, Bendahl PO, Falkenback D, Halvarsson B and Nilbert M: Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer. BMC Cancer 8: 98, 2008.
25. Lassmann S, Weis R, Makowiec F, Roth J, Danciu M, Hopt U and Werner M: Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med 85: 293-304, 2007.
26. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Durst M, Schneider A, Pothuri B, Mansukhani M, Basso K, Chaganti RS and Murty VV: Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and over-expressed genes. Genes Chromosomes Cancer 46: 373-384, 2007.
27. Kasahara K, Taguchi T, Yamasaki I, Kamada M and Shuin T: Genetic changes in localized prostate cancer of Japanese patients shown by comparative genomic hybridization. Cancer Genet Cytogenet 159: 84-88, 2005.
28. Cardillo MR, Di Silverio F and Gentile V: Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer. Anticancer Res 26: 973-982, 2006.
29. Albayrak S, Canguven O, Goktas C, Aydemir H and Koksal V: Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population. Urol Int 79: 312-315, 2007.
30. Tsuchiya N, Mishina M, Narita S, Kumazawa T, Inoue T, Horikawa Y, Kakinuma H, Yuasa T, Matsuura S, Satoh S, Ogawa O and Habuchi T: Association of XRCC1 gene polymorphisms with the susceptibility and chromosomal aberration of testicular germ cell tumors. Int J Oncol 28: 1217-1223, 2006.
31. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE and Wein A: A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154: 131-138, 1995.
32. Shimizu Y, Kondo S, Shirai A, Furukawa M and Yoshizaki T: A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 35: 381-389, 2008.
33. Puente XS, Sanchez LM, Overall CM and Lopez-Otin C: Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4: 544-558, 2003.
34. Noll WW, Belloni DR, Rutter JL, Storm CA, Schned AR, Titus-Ernstoff L, Ernstoff MS and Brinckerhoff CE: Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am J Pathol 158: 691-697, 2001.
35. Pendas AM, Matilla T, Estivill X and Lopez-Otin C: The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics 26: 615-618, 1995.
36. Ye S, Dhillon S, Turner SJ, Bateman AC, Theaker JM, Pickering RM, Day I and Howell WM: Invasiveness of cutaneous malignant melanoma is influenced by matrix metallo-proteinase 1 gene polymorphism. Cancer Res 61: 1296-1298, 2001.
37. Sternlicht MD, Bissell MJ and Werb Z: The matrix metallo-proteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19: 1102-1113, 2000.